Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

NICE image

NICE recommends Xgeva for bone metastasis

March 29, 2012 Sales and Marketing Amgen, NICE, Xgeva, Zytiga, denosumab, prostate cancer

NICE has issued draft guidance recommending Amgen’s Xgeva (denosumab) for certain groups of cancer patients whose disease has spread to …
News

Approval for Affymax and Takeda’s anaemia treatment

March 29, 2012 Sales and Marketing Affymax, Amgen, ESA, Epogen, Takeda, omontys

The first rival treatment to Amgen’s portfolio of anaemia drugs has been approved in the US.Omontys (peginesatide) has been developed …
News
a_mahmoud

Inovio appoints ex-Merck vaccines president Dr Adel Mahmoud

March 29, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Inovio, Merck, vaccines

Inovio Pharmaceuticals has announced that Dr Adel Mahmoud has been appointed to its Board of Directors.  Mahmoud, a global infectious …
Appointment

Prostate cancer drug extends life after chemotherapy

March 29, 2012 Research and Development, Sales and Marketing Astellas, Medivation, Zytiga, prostate cancer

Prostate cancer treatment MDV3100 has been shown to extend life by nearly five months in men with advanced disease who …
News
GSK image

GSK settles cancer patent dispute

March 28, 2012 Research and Development, Sales and Marketing GSK, Genmab, Roche, ofatumumab, patents

GlaxoSmithKline has settled a long-running patent dispute over its cancer treatment ofatumumab.  The US patents, which relate to recombinant antibody …
News

NHS reforms become law

March 28, 2012 Sales and Marketing CCGs, Commissioning Board, Lansley, NHS, PCTs, QIPP, reforms

After 18 months of political wrangling and mass opposition, the government’s reform of the NHS in England has been passed …
News
Amgen picture

Sanofi sets up cholesterol drug showdown with Amgen

March 27, 2012 Research and Development, Sales and Marketing Amgen, BMS, LDL, Lipitor, Merck, Regeneron, Sanofi

Sanofi and Amgen have posted results for their new injectable cholesterol drugs within 24 hours of each other.  Both drugs …
News

Risk register spells out NHS reform risks

March 27, 2012 Sales and Marketing NHS reforms, commissioning, health bill, risk register

A leaked document that assesses problems with the government’s reform of the NHS has been published by the Guardian. The …
News
Quetiapine image

Teva launches generic Seroquel in UK

March 27, 2012 Sales and Marketing AZ, NHS, Quetiapine, Seroquel, Teva

Teva has launched a generic version of the antipsychotic Seroquel on the same day AstraZeneca loses patent protection on its …
News

UK government launches new dementia programme

March 26, 2012 Medical Communications, Sales and Marketing Alzheimer's, Cameron, UK, dementia

The government has signalled its intention to boost dementia funding and awareness with its new ‘challenge on dementia’ campaign.  In …
News

HPI strengthens healthcare and pharma presence with new hire

March 26, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

HPI has strengthened its presence in the healthcare and pharma sectors with the appointment of Marianne MacDonell. She will head …
Appointment

UCB nominates new board members

March 26, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing UCB, board members

UCB has nominated Harriet Edelman and Charles-Antoine Janssen to become new members of UCB’s board of directors. The new nominations …
Appointment
NICE hq pic

NICE looking into unlicensed and off-label drug use

March 26, 2012 Sales and Marketing DoH, NICE, off label, off-label, postcode, unlicensed

NICE is reviewing the use of off-label and unlicensed medicines across the NHS in England. This follows a pilot project …
News

Rare diseases – pharma’s new frontier

March 26, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Pharma, CAPS, McConaghie, rare diseases

The last ten years has seen our understanding of rare diseases move ahead rapidly, often thanks to greater understanding of …
Feature

High Court rules against Seroquel XR patent

March 23, 2012 Sales and Marketing Accord, AstraZeneca, Sandoz, Seroquel, Teva

A British High Court has ruled that AstraZeneca’s patent on its new formulation of the antipsychotic Seroquel is invalid. Seroquel …
News
The Gateway to Local Adoption Series

Latest content

Closing the immunisation gap: partnership working that delivered at scale

June 3, 2026

China approves fruquintinib combination for kidney cancer

May 29, 2026

BIOTRONIK, Charité and GHCF launch digital cardiology partnership

May 28, 2026

Endometriosis study begins recruitment in UK hospitals

May 28, 2026

MHRA authorises donidalorsen for hereditary angioedema prevention

May 27, 2026